Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Noncoding regions are the main source of targetable tumor-specific antigens.

Laumont CM, Vincent K, Hesnard L, Audemard É, Bonneil É, Laverdure JP, Gendron P, Courcelles M, Hardy MP, Côté C, Durette C, St-Pierre C, Benhammadi M, Lanoix J, Vobecky S, Haddad E, Lemieux S, Thibault P, Perreault C.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau5516. doi: 10.1126/scitranslmed.aau5516.

PMID:
30518613
2.

Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods.

Lanoix J, Durette C, Courcelles M, Cossette É, Comtois-Marotte S, Hardy MP, Côté C, Perreault C, Thibault P.

Proteomics. 2018 Jun;18(12):e1700251. doi: 10.1002/pmic.201700251. Epub 2018 Apr 24.

PMID:
29508533
3.

Seasonal flu vaccination: a matter of choice?

Lanoix JP, Douadi C, El Samad Y, Schmit JL.

J Hosp Infect. 2017 Jul;96(3):302-303. doi: 10.1016/j.jhin.2017.04.016. Epub 2017 Apr 22. No abstract available.

PMID:
28522010
4.

In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.

Gopal P, Tasneen R, Yee M, Lanoix JP, Sarathy J, Rasic G, Li L, Dartois V, Nuermberger E, Dick T.

ACS Infect Dis. 2017 Jul 14;3(7):492-501. doi: 10.1021/acsinfecdis.7b00017. Epub 2017 Mar 16.

5.

Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections.

El Samad Y, Lanoix JP, Bennis Y, Diouf M, Saroufim C, Brunschweiler B, Rousseau F, Joseph C, Hamdad F, Ait Amer Meziane M, Routier S, Schmit JL.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6365-8. doi: 10.1128/AAC.00351-16. Print 2016 Oct.

6.

High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.

Lanoix JP, Tasneen R, O'Brien P, Sarathy J, Safi H, Pinn M, Alland D, Dartois V, Nuermberger E.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4197-205. doi: 10.1128/AAC.03085-15. Print 2016 Jul.

7.

Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression.

Croisé P, Houy S, Gand M, Lanoix J, Calco V, Tóth P, Brunaud L, Lomazzi S, Paramithiotis E, Chelsky D, Ory S, Gasman S.

Endocr Relat Cancer. 2016 Apr;23(4):281-93. doi: 10.1530/ERC-15-0502. Epub 2016 Feb 24.

PMID:
26911374
8.

Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.

Lanoix JP, Betoudji F, Nuermberger E.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1091-6. doi: 10.1128/AAC.02637-15. Print 2016 Feb.

9.

Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.

Lanoix JP, Ioerger T, Ormond A, Kaya F, Sacchettini J, Dartois V, Nuermberger E.

Antimicrob Agents Chemother. 2015 Nov 16;60(2):735-43. doi: 10.1128/AAC.01370-15. Print 2016 Feb.

10.

Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?

Lanoix JP, Chaisson RE, Nuermberger EL.

Clin Infect Dis. 2016 Feb 15;62(4):484-90. doi: 10.1093/cid/civ911. Epub 2015 Nov 1.

11.

Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.

Via LE, Savic R, Weiner DM, Zimmerman MD, Prideaux B, Irwin SM, Lyon E, O'Brien P, Gopal P, Eum S, Lee M, Lanoix JP, Dutta NK, Shim T, Cho JS, Kim W, Karakousis PC, Lenaerts A, Nuermberger E, Barry CE 3rd, Dartois V.

ACS Infect Dis. 2015 May 8;1(5):203-214.

12.

Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis.

Lanoix JP, Lenaerts AJ, Nuermberger EL.

Dis Model Mech. 2015 Jun;8(6):603-10. doi: 10.1242/dmm.019513. Epub 2015 Mar 30.

13.

Correction for lanoix et Al., novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosis.

Lanoix JP, Betoudji F, Nuermberger E.

Antimicrob Agents Chemother. 2015 Mar;59(3):1826. doi: 10.1128/AAC.05096-14. No abstract available.

14.

[Fanconi syndrome in a 22-year-old African patient].

Wetzstein M, Jauréguy M, Lanoix JP, Poulain C, Berrou C, Renou M, Cordonnier C, Choukroun G.

Nephrol Ther. 2014 Nov;10(6):471-4. doi: 10.1016/j.nephro.2014.06.004. Epub 2014 Oct 14. French.

PMID:
25439108
15.

Tuberculosis in the intensive care unit: a descriptive analysis in a low-burden country.

Lanoix JP, Gaudry S, Flicoteaux R, Ruimy R, Wolff M.

Int J Tuberc Lung Dis. 2014 May;18(5):581-7. doi: 10.5588/ijtld.13.0901.

PMID:
24903796
16.

Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosis.

Lanoix JP, Betoudji F, Nuermberger E.

Antimicrob Agents Chemother. 2014;58(4):2316-21. doi: 10.1128/AAC.02658-13. Epub 2014 Feb 3. Erratum in: Antimicrob Agents Chemother. 2015 Mar;59(3):1826.

17.

Bacterial lung sepsis in patients with febrile neutropenia.

Lanoix JP, Schmit JL, Douadi Y.

Curr Opin Pulm Med. 2012 May;18(3):175-80. doi: 10.1097/MCP.0b013e328351f8e8. Review.

PMID:
22343426
18.

Assessing urine human papillomavirus polymerase chain reaction testing as a tool for screening anal HPV infection in HIV-positive MSM.

Lanoix JP, Pannier C, Borel A, El Samad Y, Robin C, Douadi Y, Woimant M, Fouche B, Lecaque C, Ganry O, Duverlie G, Sevestre H, Schmit JL.

AIDS Patient Care STDS. 2012 Apr;26(4):208-13. doi: 10.1089/apc.2011.0301. Epub 2012 Feb 9.

PMID:
22320265
19.

Risk factors for prolonged treatment of lymph node tuberculosis.

Lanoix JP, Guimard T, Ettahar N, Grannec A, Flateau C, Chapuzet C, Bentayeb H, Tattevin P, Schmit JL.

Int J Tuberc Lung Dis. 2012;16(3):373-5. doi: 10.5588/ijtld.11.0470. Epub 2012 Jan 5.

PMID:
22230257
20.

Sphingomonas paucimobilis bacteremia related to intravenous human immunoglobulin injections.

Lanoix JP, Hamdad F, Borel A, Thomas D, Salle V, Smail A, El Samad Y, Schmit JL.

Med Mal Infect. 2012 Jan;42(1):37-9. doi: 10.1016/j.medmal.2011.10.002. Epub 2011 Nov 8. No abstract available.

PMID:
22075255
21.

Bacterial infection profiles in lung cancer patients with febrile neutropenia.

Lanoix JP, Pluquet E, Lescure FX, Bentayeb H, Lecuyer E, Boutemy M, Dumont P, Jounieaux V, Schmit JL, Dayen C, Douadi Y.

BMC Infect Dis. 2011 Jun 27;11:183. doi: 10.1186/1471-2334-11-183.

22.

Antiretroviral therapy in intensive care.

Lanoix JP, Andrejak C, Schmit JL.

Med Mal Infect. 2011 Jul;41(7):353-8. doi: 10.1016/j.medmal.2011.05.001. Epub 2011 Jun 15. Review.

PMID:
21680122
23.

Neisseria meningitidis serogroup B meningitis relapse after five days of cefotaxime treatment: what went wrong?

Lanoix JP, Lecerf C, El Samad Y, Rousseau F, Tchaoussoff J, Schmit JL.

Scand J Infect Dis. 2011 Oct;43(10):830-2. doi: 10.3109/00365548.2011.582142. Epub 2011 May 26.

PMID:
21612559
24.

Taking organelles apart, putting them back together and creating new ones: lessons from the endoplasmic reticulum.

Lavoie C, Roy L, Lanoix J, Taheri M, Young R, Thibault G, Farah CA, Leclerc N, Paiement J.

Prog Histochem Cytochem. 2011 Jun;46(1):1-48. doi: 10.1016/j.proghi.2011.04.001. Epub 2011 May 4. Review.

PMID:
21536318
25.

[Lymph node tuberculosis treatment: from recommendations to practice].

Lanoix JP, Douadi Y, Borel A, Andrejak C, El Samad Y, Ducroix JP, Schmit JL.

Med Mal Infect. 2011 Feb;41(2):87-91. doi: 10.1016/j.medmal.2010.09.007. Epub 2010 Nov 23. French.

PMID:
21106315
26.

Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.

Lanoix JP, Bourgeois AM, Schmidt J, Desblache J, Salle V, Smail A, Mazière JC, Betsou F, Choukroun G, Duhaut P, Ducroix JP.

Lupus. 2011 Feb;20(2):125-30. doi: 10.1177/0961203310378862. Epub 2010 Oct 11.

PMID:
20937623
27.

Proteomic analysis of the transitional endoplasmic reticulum in hepatocellular carcinoma: an organelle perspective on cancer.

Roy L, Laboissière S, Abdou E, Thibault G, Hamel N, Taheri M, Boismenu D, Lanoix J, Kearney RE, Paiement J.

Biochim Biophys Acta. 2010 Sep;1804(9):1869-81. doi: 10.1016/j.bbapap.2010.05.008. Epub 2010 Jun 4.

PMID:
20576523
28.

Secretory vesicle analysis for discovery of low abundance plasma biomarkers.

Lanoix J, Paramithiotis E.

Expert Opin Med Diagn. 2008 May;2(5):475-85. doi: 10.1517/17530059.2.5.475.

PMID:
23495737
29.

Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens.

Sircar K, Gaboury L, Ouadi L, Mecteau M, Scarlata E, Saad F, Aprikian A, Tanguay S, Lapointe S, Lussier C, Miletti T, Lanoix J.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4178-84.

30.
31.

Sorting of Golgi resident proteins into different subpopulations of COPI vesicles: a role for ArfGAP1.

Lanoix J, Ouwendijk J, Stark A, Szafer E, Cassel D, Dejgaard K, Weiss M, Nilsson T.

J Cell Biol. 2001 Dec 24;155(7):1199-212. Epub 2001 Dec 17.

32.

GTP hydrolysis by arf-1 mediates sorting and concentration of Golgi resident enzymes into functional COP I vesicles.

Lanoix J, Ouwendijk J, Lin CC, Stark A, Love HD, Ostermann J, Nilsson T.

EMBO J. 1999 Sep 15;18(18):4935-48.

33.
34.

Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression.

Trudel M, Barisoni L, Lanoix J, D'Agati V.

Am J Pathol. 1998 Jan;152(1):219-29.

35.

C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.

Trudel M, Lanoix J, Barisoni L, Blouin MJ, Desforges M, L'Italien C, D'Agati V.

J Exp Med. 1997 Dec 1;186(11):1873-84.

36.

Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).

Lanoix J, D'Agati V, Szabolcs M, Trudel M.

Oncogene. 1996 Sep 19;13(6):1153-60.

PMID:
8808689
37.

Cell-free assembly of rough and smooth endoplasmic reticulum.

Lavoie C, Lanoix J, Kan FW, Paiement J.

J Cell Sci. 1996 Jun;109 ( Pt 6):1415-25.

38.
39.

Interactions between HTLV-I Tax and NF-kappa B/Rel proteins in T cells.

Lacoste J, Lanoix J, Pepin N, Hiscott J.

Leukemia. 1994 Apr;8 Suppl 1:S71-6.

PMID:
8152309
40.
41.

Action of spontaneously produced beta interferon in differentiation of embryonal carcinoma cells through an autoinduction mechanism.

Belhumeur P, Lanoix J, Blais Y, Forget D, Steyaert A, Skup D.

Mol Cell Biol. 1993 May;13(5):2846-57.

42.

Regulation of the expression of lamins A and C is post-transcriptional in P19 embryonal carcinoma cells.

Lanoix J, Skup D, Collard JF, Raymond Y.

Biochem Biophys Res Commun. 1992 Dec 30;189(3):1639-44.

PMID:
1282809
44.

cAMP-dependent phosphorylation of RER proteins from rat liver: relationship with GTP-dependent membrane fusion.

Lanoix J, Paiement J.

Biochem Biophys Res Commun. 1991 Aug 30;179(1):463-70.

PMID:
1652958
45.

Regulated expression of Krox-24 and other serum-responsive genes during differentiation of P19 embryonal carcinoma cells.

Lanoix J, Belhumeur P, Lussier M, Royal A, Bravo R, Skup D.

Cell Growth Differ. 1991 Aug;2(8):391-9.

46.

Localization of ras antigenicity in rat hepatocyte plasma membrane and rough endoplasmic reticulum fractions.

Dominguez JM, Lanoix J, Paiement J.

Exp Cell Res. 1991 Jan;192(1):137-47.

PMID:
1898589
47.

Cytological effects of the microinjection of antibody to ras p21 in early cleavage Xenopus embryos.

Miron MJ, Lanoix J, Paiement J.

Mol Reprod Dev. 1990 Apr;25(4):317-27.

PMID:
2183830
48.
49.

Supplemental Content

Loading ...
Support Center